Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16018016 | 0.88 | CYP3A4 (0.68) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| Xanthoxylin SCHEMBL44708 | 0.88 | CYP3A4 (1.00) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| Xanthoxylin SCHEMBL29349586 | 0.88 | CYP3A4 (1.00) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL1156165 | 0.87 | CYP3A4 (0.62) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL16009934 | 0.86 | CYP3A4 (0.66) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL2203125 | 0.86 | CYP3A4 (0.66) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| Xanthoxylin SCHEMBL28802531 | 0.86 | CYP3A4 (0.96) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL23327124 | 0.86 | CYP3A4 (0.60) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL30545309 | 0.86 | CYP3A4 (0.60) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A | |
| SCHEMBL12303218 | 0.85 | CYP3A4 (0.64) | CYP3A4USP2MAPK1SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956226-A | Method for synthesizing carvachin | 南京科技职业学院 | 2022-01-21 | — | — | CN | claimed |
| CN-112824370-A | Method for synthesizing pentamethoxyl chalcone | 南京科技职业学院 | 2021-05-21 | — | — | CN | claimed |
| CN-112778208-A | Dihydropyrazole MurA enzyme inhibitor molecule and preparation method and application thereof | 中南民族大学 | 2021-05-11 | — | — | CN | claimed |
| US-9174906-B2 | Process for producing optically active secondary alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-11-03 | — | — | US | claimed |
| EP-1778176-B1 | COMPOSITION FOR COLOURING KERATIN-CONTAINING FIBRES | HENKEL AG & CO KGAA (DE) | 2012-07-25 | — | — | EP | claimed |
| EP-2340239-A2 | SYNTHESIS OF MYRTUCOMMULON A AND MYRTUCOMMULON ANALOGUES | Universität des Saarlandes (DE) | 2011-07-06 | — | — | EP | claimed |
| WO-2010022953-A2 | SYNTHESIS OF MYRTUCOMMULON A AND MYRTUCOMMULON ANALOGUES | Universität des Saarlandes (DE) | 2010-03-04 | — | — | WO | claimed |
| US-7413579-B2 | Method for dyeing fibers containing keratin | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-08-19 | — | — | US | claimed |
| EP-1432388-B1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | HENKEL AG & CO KGAA (DE) | 2008-06-18 | — | — | EP | claimed |
| US-7300472-B2 | Agents for coloring fibers containing keratin | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-11-27 | — | — | US | claimed |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-12-01 | — | — | US | claimed |
| EP-1434557-B1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-11-09 | — | — | EP | claimed |
| EP-1585489-A2 | AGENT FOR DYEING FIBRES CONTAINING KERATIN | Henkel Kommanditgesellschaft auf Aktien (DE) | 2005-10-19 | — | — | EP | claimed |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2005-07-07 | — | — | US | claimed |
| WO-2004058203-A2 | AGENT FOR DYEING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (US) | 2004-07-15 | — | — | WO | claimed |
| EP-1432388-A1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-30 | — | — | EP | claimed |
| EP-1433469-A1 | Composition for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-30 | — | — | EP | claimed |
| WO-2003030847-A1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-04-17 | — | — | WO | claimed |
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| EP-1300133-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | KRT18, TUBB3, DSG1 | CYP3A4 2086/4885USP2 3357/4885MAPK1 1557/4885 |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | KRT18, CKAP4, KRTCAP2 | CYP3A4 1707/4885USP2 2832/4885MAPK1 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.